NU/1246-1 STEMGEL: Commercialisation of university research through provision of management skills to assist in successful spin-out company creation
What the buyer wrote
Prof. Che Connon of Newcastle University has invented a cell encapsulation technology which provides a novel solution to the many problems associated with the transportation and storage of cells and cultures. The proposal is to set up a company ("StemGel") to exploit the commercial opportunities presented by the core technology platform. Those opportunities span a wide range of segments of the overall life sciences sector, including, but not limited to, research tools for the individual laboratory researcher through to new therapeutics for regenerative medicine. The business will use its core IP to provide kits for the transportation of cells in the laboratory supply and cell distribution …
Bid for this and lost? There is a short window in which the decision can be questioned.
Awarded to
Details
- What the buyer calls it
- NU/1246-1 STEMGEL: Commercialisation of university research through provision of management skills to assist in successful spin-out company creation
- How they are buying
- The buyer did not say
- Type
- services
- Work starts
- 30 Apr 2017
- Work ends
- 30 Nov 2017
- Kind of work
- Professional services, Logistics, courier and distribution
Who the buyer named
The buyer published a contact address on this notice.